Statin Use in Hospitalized DM Patients With COVID-19 Associated with Lower Mortality
Study authors assess the association between statin therapy and in-hospital mortality in patients with COVID-19 and concomitant diabetes mellitus.
Diabetes
HIV, Hepatitis-B Drugs Proven to Reduce Risk of Type 2 Diabetes
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men
Study authors investigated whether integrase strand transfer inhibitor treatment was associated with increased weight change from baseline and incident diabetes mellitus.
Risk of Diabetes Mellitus in HIV Patients With Associated cART Initiation
Researchers assessed the risk of diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the United States and Canada.
Comorbid Diabetes and COVID-19 Linked to Longer Hospitalization
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and hospital stays.
Managing SGLT2 Inhibitor-Associated Genital Mycotic Infections
Genital mycotic infection is listed as a potential adverse effect of the SGLT2 inhibitor class.
Reduced Hospitalization Among People With Diabetes With Multi-Season Influenza Vaccination
Influenza hospitalizations were decreased among people with diabetes when vaccines were received in multiple influenza seasons.
Lilly Introduces Insulin Value Program in Response to COVID-19
Lilly announced the launch of its Insulin Value Program to assist patients with or without commercial insurance with filling their monthly insulin prescriptions for $35.
Mood Disorders With HIV Increase Risk for Noncommunicable Disease
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
Adherence to antimalarials may offer a protective effect against type 2 diabetes mellitus among patients with systemic lupus erythematosus.
-
Loading...
-
Loading...
Next post in Prevention
